99.95% for ONS. 99.6% for pillar 1 and 99.2% for pillar 2.
Sorry, are you saying that the acute patient sample from Phase I/II (who have a much higher chance of COVID-19 infection than the ONS random sample) would lower the test specificity substantially?
-
-
I'm especially confused because the ONS sample was literally run "as part of the national testing scheme" which means that these are the same tests being run on samples collected in the same way, but split up into different groups
-
This Tweet is unavailable.
- Show replies
New conversation -
-
-
Yes. The chance of them being symptomatic with another infection that could cause cross reactivity has to be taken into account. The chances of that are probably low but very few numbers have been put on it and lots of low chances can add up to 0.8%.https://www.achgut.com/artikel/bericht_zur_coronalage_28.05.2020 …
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.